Jane Street’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Sell
278,890
-378,964
-58% -$2.29M ﹤0.01% 5445
2025
Q4
$3.45M Buy
657,854
+445,972
+210% +$1.76M ﹤0.01% 3818
2025
Q3
$917K Buy
211,882
+104,170
+97% +$187K ﹤0.01% 6485
2025
Q2
$113K Buy
+107,712
New +$129K ﹤0.01% 8902
2024
Q4
Sell
-14,438
Closed -$58.6K 10781
2024
Q3
$58.6K Sell
14,438
-2,220
-13% -$8.29K ﹤0.01% 9145
2024
Q2
$58.3K Sell
16,658
-36,459
-69% -$149K ﹤0.01% 8884
2024
Q1
$137K Buy
+53,117
New +$188K ﹤0.01% 8397

Other funds holding ZURA

Jane Street's ZURA Position: Q1 2026 in Review

Jane Street reduced its Zura Bio (ZURA) stake by 58% in Q1 2026, selling an estimated $2.29M and leaving 278,890 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5445.

Jane Street first reported a position in ZURA in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.45M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Jane Street held 278,890 shares of Zura Bio worth $1.66M as of Q1 2026.
  • Jane Street sold 378,964 Zura Bio shares in Q1 2026, an estimated $2.29M.
  • Zura Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5445 holding.
  • Jane Street first reported a position in Zura Bio in Q1 2024 and has held it in 7 quarters since.
  • Jane Street's Zura Bio position peaked at $3.45M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.